Skip to main content

CS DIAGNOSTICS CORP.

corporate_fare Company Profile

CS DIAGNOSTICS CORP.

CSDX·OTC·Industrial Applications And Services·CIK 0001106861

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.

CS DIAGNOSTICS CORP. (OTC:CSDX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors CSDX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Auditor Flags Going Concern, Material Weakness in Controls Amidst Dire Cash Position
  • CS Diagnostics Corp. Restates Financials, Removes $499M Asset Amidst Critical Liquidity and Going Concern Doubts
$0.0541
52-week range · as of 2026-04-15 $0.036 – $0.55
Market cap
$13.52M
Volume
29K (0.3× avg)
3-mo avg 97.2K
Live data · 2026-06-14 06:17 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CSDX - Latest Insights

CSDX
Apr 15, 2026, 3:54 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.130
Real-time Price: $0.0541 info
Change: -$0.0759 (-58%) info
Market Cap: $13.525M info
CSDX
Mar 12, 2026, 12:05 PM EDT
Filing Type: 10-12G/A
Importance Score:
10
Price at Filing: $0.2019
Real-time Price: $0.0541 info
Change: -$0.1478 (-73%) info
Market Cap: $13.525M info